SCHEMBL2736605

SCHEMBL2736605

Cc1cc(Sc2nc3ccccc3o2)c(C)nc1C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.57
ALDH1A1 P00352 5/20 0.57
LMNA P02545 4/20 0.57
HTT P42858 2/20 0.57
POLB P06746 2/20 0.57
GFER P55789 1/20 0.57
MAPT P10636 7/20 0.48
TDP1 Q9NUW8 3/20 0.48
NPSR1 Q6W5P4 2/20 0.48
MEN1 O00255 1/20 0.48
HSP90AA1 P07900 1/20 0.48
HPGD P15428 1/20 0.48
XBP1 P17861 1/20 0.48
RECQL P46063 1/20 0.48
HKDC1 Q2TB90 1/20 0.48
RAB9A P51151 6/20 0.47
MAPK1 P28482 3/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
DDAH1 O94760 1/20 0.47
ADRA2C P18825 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28822248 0.79 KMT2A (0.55) KMT2AALDH1A1LMNAHTTPOLB
SCHEMBL28366757 0.77 DDAH1 (0.59) KMT2AALDH1A1LMNAHTTPOLB
SCHEMBL2736490 0.76 ALDH1A1 (0.46) KMT2AALDH1A1LMNAHTTPOLB
SCHEMBL28030477 0.72 DDAH1 (0.54) KMT2AALDH1A1LMNAHTTPOLB
SCHEMBL8363008 0.72 RAB9A (0.58) KMT2AALDH1A1LMNAHTTPOLB
SCHEMBL10587516 0.71 DDAH1 (0.53) KMT2AALDH1A1LMNAHTTPOLB
SCHEMBL215835 0.70 CNR2 (0.62) KMT2AALDH1A1LMNAHTTPOLB
SCHEMBL31155591 0.70 ELANE (0.58) KMT2AALDH1A1LMNAHTTPOLB
SCHEMBL303847 0.70 ELANE (0.58) KMT2AALDH1A1LMNAHTTPOLB
SCHEMBL10333288 0.70 ALDH1A1 (0.43) KMT2AALDH1A1LMNAHTTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088924-B2 Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor SHIONOGI & CO., LTD. (JP) 2012-01-03 US disclosed
US-20100081686-A1 Pyridone derivatives having a binding activity to the cannabinoid type 2 recepter TADA YUKIO 2010-04-01 US disclosed
US-7652141-B2 Immunosuppressants, analgesics, antiinflammatory agents SHIONOGI & CO., LTD. (JP) 2010-01-26 US disclosed
US-20080312292-A1 Antipruritics YASUI KIYOSHI 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100081686-A1 Pyridone derivatives having a binding activity to the cannabinoid type 2 recepter CNR2, CNR1, NPY2R KMT2A 2963/4885ALDH1A1 3078/4885LMNA 3511/4885
US-20080312292-A1 Antipruritics CNR1, CNR2, OPRL1 KMT2A 2819/4885ALDH1A1 3580/4885LMNA 4604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.